Navigation Links
Remicade Emerges as a Treatment for Patients Suffering From Psoriasis Disorder

Phase 3 trials conducted on Remicade (infliximab) showed rapid, significant improvement in patients with moderate to severe plaque psoriasis. The stud mainly used placebo-// control and dose-ranging from 3 mg/kg and 5 mg/kg. The continuous eight week maintenance therapy resulted in greater long-term skin clearance compared with as-needed therapy regimens within each dose.

At 10 weeks it was seen that 70 % of the patients treated with Remicade 3 mg/kg and 75 % of patients receiving 5 mg/kg achieved at least 75 % improvement in psoriasis. The measurement scale used was Psoriasis Area Severity Index (PASI 75). At the end of the 50 weeks patients receiving Remicade 5 mg/kg every eight-week maintenance therapy saw the highest level of improvement. The results were presented at the 64th annual American Academy of Dermatology meeting.

Alan Menter, MD, chairman, Division of Dermatology, Baylor University Medical Center, and lead study investigator said that patients receiving scheduled Remicade maintenance therapy achieved long-term cure against psoriasis, a lifelong, chronic inflammatory disease. Statistics show that nearly two million Americans suffer from this disease.

Robert Matheson, MD, Oregon Medical Research Center, and study investigator said that Remicade in the treatment of a disease offers great physical and emotional challenges. It has a potential to result in complete skin clearance.

The United States Food and Drug Administration (FDA) accepted the use of Remicade in the treatment of moderate to severe plaque psoriasis. Hence the European Commission also approved Remicade for the treatment of moderate to severe plaque psoriasis in adults who failed to respond to other systemic therapy.


'"/>




Page: 1

Related medicine news :

1. Remicade Therapy Effective in Treating Severe Psoriasis
2. Sanitation Emerges as the Winner
3. Advances in Treatment of Cataracts
4. Recommendations for Treatment of Blood Pressue
5. Treatment for Menieres disease
6. Treatment for pre-menstrual syndrome is ineffective
7. Better Treatment for obesity
8. Gene Treatment for Heart Disease
9. More People Seeking Treatment for Depression
10. Focused Treatment For Childhood Cancer
11. Inadequate Drug Treatment For Youth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2017)... Rosa, CA (PRWEB) , ... July 23, 2017 , ... ... of Medicine in St. Louis, and led by the Minneapolis Veterans Administration Health Care ... early stages of the disease offers very few benefits. , In the cases ...
(Date:7/23/2017)... CANADA (PRWEB) , ... July 23, 2017 , ... Specializing ... way to gain that elusive college scholarship or even go on to the pros. ... Annual Meeting in Toronto, Canada today say “not so fast.” , “Our ...
(Date:7/23/2017)... ... July 23, 2017 , ... Longtime Brevard County pain ... Melbourne, a practice owned by Physician Partners of America at 109 Silver Palm ... also is certified in pediatrics, emergency medicine and anesthesiology. , A longtime practitioner ...
(Date:7/22/2017)... ... July 21, 2017 , ... Reassured For Life ( http://www.reassured.ca ), is ... says owner and licensed broker Nerissa McNaughton. “I launched this firm because I know ... is a very necessary conversation. I make it easy. As a broker I have ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung medicine managing chest ... on the market," said an inventor from Center Valley, Pa. "My idea is to ... , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient means ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... WASHINGTON , July 21, 2017 Did you know ... (R&D) in 2016? Or that combined spending on brand medicines, generics ... health spending, with brands accounting for just half of this (7 ... for two thirds of the world,s venture capital investments in high-growth ... ...
(Date:7/19/2017)... July 19, 2017  Mako Medical Laboratories partnered with ... Military Family Assistance Fund (MFA) to bring 140 soldiers ... visit with their families one last time before being ... the travel and logistics needed for these soldiers. "Mako ... and their families. We just wish we could bring ...
(Date:7/15/2017)... 2017 Enterin Inc., a Philadelphia ... (PD), today announced the completion of a $12.7 million Series ... III, as well as the participation of existing investors. ... have the support of New Ventures III and our current ... of the potential of our platform technology to transform the ...
Breaking Medicine Technology: